- Home
- JSPR vs REAL Comparison
JSPR vs REAL Comparison
Compare JSPR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- REAL
- Stock Information
- Founded
- JSPR 2018
- REAL 2011
- Country
- JSPR United States
- REAL United States
- Employees
- JSPR N/A
- REAL N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- JSPR Health Care
- REAL Consumer Discretionary
- Exchange
- JSPR Nasdaq
- REAL Nasdaq
- Market Cap
- JSPR 323.0M
- REAL 295.1M
- IPO Year
- JSPR N/A
- REAL 2019
- Fundamental
- Price
- JSPR $22.48
- REAL $6.44
- Analyst Decision
- JSPR Strong Buy
- REAL Buy
- Analyst Count
- JSPR 11
- REAL 6
- Target Price
- JSPR $73.38
- REAL $4.13
- AVG Volume (30 Days)
- JSPR 206.1K
- REAL 2.6M
- Earning Date
- JSPR 11-07-2024
- REAL 11-04-2024
- Dividend Yield
- JSPR N/A
- REAL N/A
- EPS Growth
- JSPR N/A
- REAL N/A
- EPS
- JSPR N/A
- REAL N/A
- Revenue
- JSPR N/A
- REAL $579,862,000.00
- Revenue This Year
- JSPR N/A
- REAL $11.29
- Revenue Next Year
- JSPR N/A
- REAL $8.00
- P/E Ratio
- JSPR N/A
- REAL N/A
- Revenue Growth
- JSPR N/A
- REAL 2.52
- 52 Week Low
- JSPR $4.00
- REAL $1.52
- 52 Week High
- JSPR $31.01
- REAL $6.57
- Technical
- Relative Strength Index (RSI)
- JSPR 52.21
- REAL 86.79
- Support Level
- JSPR $20.73
- REAL $5.70
- Resistance Level
- JSPR $26.05
- REAL $6.13
- Average True Range (ATR)
- JSPR 1.60
- REAL 0.37
- MACD
- JSPR -0.10
- REAL 0.13
- Stochastic Oscillator
- JSPR 48.48
- REAL 95.15
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.